Bienzobas

Founded in 2000 by Eliseo and Paula García, Bienzobas is a Spanish company specializing in the management of cancer patients and providing oncology prescription advisory services. The firm operates on the principles of Value-Based Healthcare, aiming to optimize oncological care for clients such as insurance companies, hospitals, and public health systems. Its business model involves either direct management of a patient's cancer treatment costs and care through its physician network or acting as a consultant for external oncologists. Both services utilize the proprietary Bienzobas Oncology Platform, an IT tool that evaluates proposed treatment plans against established national and international clinical guidelines for efficacy and safety.

The company's platform leverages cloud systems, Big Data, and AI to enhance healthcare management, support clinical decision-making, and improve patient monitoring. Bienzobas maintains a network of over 70 oncologists across more than 40 medical centers, handling over 15,000 consultations annually for a population of over two million insured individuals. In February 2020, private equity firm Nexxus Iberia acquired a majority stake to foster growth and international expansion, which included an entry into Mexico through the acquisition of Cuidarte.

In June 2022, Atrys Health, a global precision medicine company, acquired 100% of Bienzobas for approximately €76.3 million to create a comprehensive 360-degree oncology service model. At the time of the acquisition, Bienzobas had reported revenues of €30.62 million for the 2021 fiscal year. The acquisition integrated Bienzobas's management platform and expertise into Atrys's broader portfolio of prevention, diagnosis, and treatment services.

Keywords: oncology services, cancer care management, prescription advisory, value-based healthcare, clinical guidelines, oncology platform, health insurance, medical consulting, evidence-based medicine, patient management